The impact of beam angle configuration of intensity-modulated radiotherapy in the hepatocellular carcinoma

Sung Hoon Kim, Min Kyu Kang, Ji Woon Yea, Sung Kyu Kim, Ji Hoon Choi, Se An Oh

Research output: Contribution to journalArticlepeer-review

7 Scopus citations

Abstract

Purpose: This treatment planning study was undertaken to evaluate the impact of beam angle configuration of intensity-modulated radiotherapy (IMRT) on the dose of the normal liver in hepatocellular carcinoma (HCC). Materials and Methods: The computed tomography datasets of 25 patients treated with IMRT for HCC were selected. Two IMRT plans using five beams were made in each patient; beams with equidistance of 72° (Plan I), and beams with a 30° angle of separation entering the body near the tumor (Plan II). Both plans were generated using the same constraints in each patient. Conformity index (CI), homogeneity index (HI), gamma index, mean dose of the normal liver (Dmean_NL), Dmean_NL difference between the two plans, and percentage normal liver volumes receiving at least 10, 20, and 30 Gy (V10, V20, and V30) were evaluated and compared. Results: Dmean_NL, V10, and V20 were significantly better for Plan II. The Dmean_NL was significantly lower for peripheral (p = 0.001) and central tumors (p = 0.034). Dmean_NL differences between the two plans increased in proportion to gross tumor volume to normal liver volume ratios (p = 0.002). CI, HI, and gamma indices were not significantly different for the two plans. Conclusion: The IMRT plan based on beams with narrow separations reduced the irradiated dose of the normal liver, which would allow radiation dose escalation for HCC.

Original languageEnglish
Pages (from-to)146-151
Number of pages6
JournalRadiation Oncology Journal
Volume30
Issue number3
DOIs
StatePublished - 2012

Keywords

  • Hepatocellular carcinoma
  • Intensity modulated radiation therapy
  • Radiation therapy

Fingerprint

Dive into the research topics of 'The impact of beam angle configuration of intensity-modulated radiotherapy in the hepatocellular carcinoma'. Together they form a unique fingerprint.

Cite this